bone resorption

Summary

Summary: Bone loss due to osteoclastic activity.

Top Publications

  1. ncbi Glucocorticoid-induced osteoporosis: an update
    Gherardo Mazziotti
    Department of Internal Medicine, Spedali Civili, University of Brescia, 25125 Brescia, Italy
    Trends Endocrinol Metab 17:144-9. 2006
  2. ncbi [Diagnosis and treatment of immobilization osteoporosis]
    Daisuke Inoue
    Third Department of Medicine, Teikyo University Chiba Medical Center
    Nippon Rinsho 65:514-9. 2007
  3. ncbi Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    D L Lacey
    Department of Pathology, Amgen, Inc, Thousand Oaks, California 91320 1789, USA
    Cell 93:165-76. 1998
  4. ncbi Osteoprotegerin: a novel secreted protein involved in the regulation of bone density
    W S Simonet
    Department of Molecular Genetics, Amgen Inc, Thousand Oaks, California 91320, USA
    Cell 89:309-19. 1997
  5. ncbi Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
    Hiroshi Takayanagi
    Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Yushima 1 5 45, Bunkyo ku, Tokyo 113 8549, Japan
    Nat Rev Immunol 7:292-304. 2007
  6. ncbi The molecular understanding of osteoclast differentiation
    Masataka Asagiri
    Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Yushima 1 5 45, Tokyo 113 8549, Japan
    Bone 40:251-64. 2007
  7. ncbi IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
    Steeve Kwan Tat
    , , 1 rue Gaston Veil, BP 53508, 44035 Nantes 1, France
    Cytokine Growth Factor Rev 15:49-60. 2004
  8. ncbi Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts
    K P McHugh
    Department of Pathology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Clin Invest 105:433-40. 2000
  9. ncbi Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity
    Estabelle S M Ang
    Molecular Orthopaedic Laboratory, Centre for Orthopaedic Research, School of Surgery, The University of Western Australia, Nedlands, Western Australia, Australia
    J Cell Physiol 221:642-9. 2009
  10. ncbi Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model
    XiaoYan Tian
    Radiobiology Division, University of Utah School of Medicine, Salt Lake City, UT, USA
    Bone 48:197-201. 2011

Research Grants

  1. Biomaterials (Mf/Zn/F-BCPs) for osteoporosis therapy
    Racquel LeGeros; Fiscal Year: 2009
  2. Biomaterials (Mf/Zn/F-BCPs) for osteoporosis therapy
    RACQUEL ZAPANTA LEGEROS; Fiscal Year: 2010
  3. DEGRADABLE HYDROGELS FOR ORAL DELIVERY OF CALCITONIN
    Jindrich Kopecek; Fiscal Year: 2003
  4. BONE MATRIX AND BONE RESORPTION
    Paul R Odgren; Fiscal Year: 2010
  5. PDGF D AND PROSTATE CANCER BONE METASTASIS
    Hyeong Reh Choi Kim; Fiscal Year: 2010
  6. Molecular Mechanisms in Bone Resorption
    Steven A Lietman; Fiscal Year: 2010
  7. Molecular Mechanisms in Bone Resorption
    STEVEN LIETMAN; Fiscal Year: 2009
  8. Immune Cytokines Promote Oral Bone Loss Through IKK
    Cun Yu Wang; Fiscal Year: 2010
  9. Innate Immune Bacterial Recognition and Osteoclastogenesis
    Caroline A Genco; Fiscal Year: 2010
  10. The Effect of PTHrP During Lactation
    John J Wysolmerski; Fiscal Year: 2010

Detail Information

Publications270 found, 100 shown here

  1. ncbi Glucocorticoid-induced osteoporosis: an update
    Gherardo Mazziotti
    Department of Internal Medicine, Spedali Civili, University of Brescia, 25125 Brescia, Italy
    Trends Endocrinol Metab 17:144-9. 2006
    ..two phases: a rapid, early phase in which bone mineral density is reduced, possibly as a result of excessive bone resorption, and a slower, progressive phase in which bone mineral density declines because of impaired bone formation...
  2. ncbi [Diagnosis and treatment of immobilization osteoporosis]
    Daisuke Inoue
    Third Department of Medicine, Teikyo University Chiba Medical Center
    Nippon Rinsho 65:514-9. 2007
  3. ncbi Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    D L Lacey
    Department of Pathology, Amgen, Inc, Thousand Oaks, California 91320 1789, USA
    Cell 93:165-76. 1998
    ..These data suggest that OPGL is an osteoclast differentiation and activation factor. The effects of OPGL are blocked in vitro and in vivo by OPG, suggesting that OPGL and OPG are key extracellular regulators of osteoclast development...
  4. ncbi Osteoprotegerin: a novel secreted protein involved in the regulation of bone density
    W S Simonet
    Department of Molecular Genetics, Amgen Inc, Thousand Oaks, California 91320, USA
    Cell 89:309-19. 1997
    A novel secreted glycoprotein that regulates bone resorption has been identified. The protein, termed Osteoprotegerin (OPG), is a novel member of the TNF receptor superfamily...
  5. ncbi Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
    Hiroshi Takayanagi
    Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Yushima 1 5 45, Bunkyo ku, Tokyo 113 8549, Japan
    Nat Rev Immunol 7:292-304. 2007
    ....
  6. ncbi The molecular understanding of osteoclast differentiation
    Masataka Asagiri
    Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Yushima 1 5 45, Tokyo 113 8549, Japan
    Bone 40:251-64. 2007
    ..From the clinical point of view, RANKL signaling pathway has promise as a strategy for suppressing the excessive osteoclast formation characteristic of a variety of bone diseases...
  7. ncbi IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
    Steeve Kwan Tat
    , , 1 rue Gaston Veil, BP 53508, 44035 Nantes 1, France
    Cytokine Growth Factor Rev 15:49-60. 2004
    ..The interactions between these three groups are presented within the framework of bone resorption pathophysiology such as tumor associated osteolysis...
  8. ncbi Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts
    K P McHugh
    Department of Pathology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Clin Invest 105:433-40. 2000
    Osteoclasts express the alphavbeta3 integrin, an adhesion receptor that has been implicated in bone resorption and that is therefore a potential therapeutic target...
  9. ncbi Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity
    Estabelle S M Ang
    Molecular Orthopaedic Laboratory, Centre for Orthopaedic Research, School of Surgery, The University of Western Australia, Nedlands, Western Australia, Australia
    J Cell Physiol 221:642-9. 2009
    ..In this study, we investigated the effect of CAPE on the regulation of RANKL-induced osteoclastogenesis, bone resorption and signaling pathways...
  10. ncbi Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model
    XiaoYan Tian
    Radiobiology Division, University of Utah School of Medicine, Salt Lake City, UT, USA
    Bone 48:197-201. 2011
    ..in a rat immobilization/disuse model in which there was both a decrease in bone formation and an increase in bone resorption. Ten-month-old female Sprague Dawley rats were divided into normal weight-bearing (normal-loaded, NL) and ..
  11. ncbi Cellular and molecular mechanisms of bone remodeling
    Liza J Raggatt
    Faculty of Health Sciences, The University of Queensland Centre for Clinical Research, Royal Brisbane Hospital, Herston 4029, Australia
    J Biol Chem 285:25103-8. 2010
    Physiological bone remodeling is a highly coordinated process responsible for bone resorption and formation and is necessary to repair damaged bone and to maintain mineral homeostasis...
  12. ncbi I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss
    Maria Grazia Ruocco
    Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA
    J Exp Med 201:1677-87. 2005
    ..IKKbeta also protects osteoclasts and their progenitors from tumor necrosis factor alpha-induced apoptosis, and its loss in hematopoietic cells prevents inflammation-induced bone loss...
  13. ncbi DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells
    Mitsuru Yagi
    Department of Cell Differentiation, The Sakaguchi Laboratory, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
    J Exp Med 202:345-51. 2005
    ..We have thus identified an essential regulator of osteoclast and macrophage cell fusion, DC-STAMP, and an essential role of osteoclast multinucleation in bone homeostasis...
  14. ncbi MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
    K Holmbeck
    MMP Unit, National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892, USA
    Cell 99:81-92. 1999
    ....
  15. ncbi Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption
    J E Aubin
    Department of Anatomy and Cell Biology, Faculty of Medicine, University of Toronto, Ontario, Canada
    Osteoporos Int 11:905-13. 2000
    ..paradigm for both differentiation of osteoclasts and their activation has had tremendous impact on the field and opened new avenues for development of possible treatments of diseases characterized by excessive bone resorption.
  16. ncbi Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions
    Feng Chun Yang
    Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    J Clin Invest 116:2880-91. 2006
    ..Collectively, our results identify a what we believe to be a novel cellular and biochemical NF1-haploinsufficient phenotype in osteoclasts that has potential implications for the pathogenesis of NF1 bone disease...
  17. ncbi Osteoclast differentiation and activation
    William J Boyle
    Protein Pathways, Inc, Woodland Hills, California 91367, USA
    Nature 423:337-42. 2003
    ..pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass...
  18. ncbi Multiple roles of M-CSF in human osteoclastogenesis
    Jason M Hodge
    The Department of Clinical and Biomedical Sciences Barwon Health, The University of Melbourne, Geelong, Victoria 3220, Australia
    J Cell Biochem 102:759-68. 2007
    ..Modulation of M-CSF signaling is a potential therapeutic target for conditions associated with excess bone resorption.
  19. ncbi Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation
    Hong Hee Kim
    National Research Laboratory for Bone Metabolism, Department of Microbiology and Immunology, College of Medicine, Chosun University, Gwangju 501 759, Korea
    Exp Cell Res 289:368-77. 2003
    ....
  20. ncbi Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL
    Lorenz C Hofbauer
    Department of Medicine III, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
    Arthritis Rheum 60:1427-37. 2009
    ..This study was undertaken to evaluate the efficacy of denosumab, a neutralizing monoclonal antibody against human RANKL (hRANKL), in a murine model of glucocorticoid-induced osteoporosis...
  21. ncbi Osteoclast culture and resorption assays
    Elizabeth W Bradley
    Mayo Clinic Graduate School, Rochester, MN, USA
    Methods Mol Biol 455:19-35. 2008
    Bone homeostasis depends on balanced bone deposition and bone resorption, which are mediated by osteoblasts and osteoclasts, respectively. The process of bone turnover requires the coordination of these cells...
  22. ncbi Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis
    Marc Baud'huin
    INSERM, UMR S 957, Nantes F 44035, France
    J Pathol 221:77-86. 2010
    ..Overall, these data reveal that IL-34 can be entirely substituted for M-CSF in RANKL-induced osteoclastogenesis, thus identifying a new biological activity for this cytokine and a contribution to the pathogenesis of GCTs...
  23. ncbi Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation
    Mario M Zaiss
    University of Erlangen Nuremberg, Erlangen, Germany
    Arthritis Rheum 62:2328-38. 2010
    ..The aim of this study was to determine whether immune regulatory mechanisms, such as naturally occurring Treg cells, also extend their protective effects to bone homeostasis in vivo...
  24. ncbi The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss
    Christina Böhm
    Department of Internal Medicine 3, Rheumatology and Immunology, University of Erlangen Nuremberg, Erlangen, Germany
    J Immunol 183:5938-47. 2009
    ..Thus, our data show that developing specific inhibitors of the alpha-isoenzyme of p38 would be beneficial for the treatment of inflammation-induced bone destruction as observed in rheumatoid arthritis...
  25. ncbi Regulatory T cells protect from local and systemic bone destruction in arthritis
    Mario M Zaiss
    Department of Internal Medicine 3, University of Erlangen Nuremberg, Erlangen, Germany
    J Immunol 184:7238-46. 2010
    ..In this article, we show that blood markers of bone resorption inversely correlate with the amount of circulating Treg cells in healthy controls and rheumatoid arthritis ..
  26. ncbi Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes
    Se Hwan Mun
    Institute of Biomedical Sciences and Technology, Konkuk University, Chungju, Korea
    Cell Mol Life Sci 67:3883-92. 2010
    ..IL-33 eventually induced bone resorption. This study suggests that the osteoclastogenic property of IL-33 is mediated through TRAF6 as well as the ..
  27. ncbi Clinical applications of RANK-ligand inhibition
    E Romas
    Rheumatology Research Unit, St Vincent s Institute, University of Melbourne, Melbourne, Victoria, Australia
    Intern Med J 39:110-6. 2009
    ..g. denosumab) and which induce profound and sustained inhibition of bone resorption. The relative efficacy, cost-effectiveness and side-effects of targeted RANKL inhibition compared with ..
  28. ncbi Osteoclasts are active in bone forming metastases of prostate cancer patients
    Ilaria Roato
    CeRMS Center for Experimental Research and Medical Studies University and A O U San Giovanni Battista, Turin, Italy
    PLoS ONE 3:e3627. 2008
    ..In this study, we investigated ex vivo whether the osteolytic activity is present and how it is ruled in CaP patients with bone forming metastases...
  29. ncbi Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease
    C W O Ernst
    Department of Immunology, The Forsyth Institute, Boston, MA 02115, USA
    Clin Exp Immunol 148:271-80. 2007
    Periodontal disease involves multi-bacterial infections accompanied by inflammatory bone resorption lesions...
  30. ncbi Postgraduate Symposium: Positive influence of nutritional alkalinity on bone health
    E Wynn
    University Hospital CHUV, 1011 Lausanne, Switzerland
    Proc Nutr Soc 69:166-73. 2010
    ..been shown in a group of thirty young women that in Ca sufficiency an acid Ca-rich water has no effect on bone resorption, while an alkaline bicarbonate-rich water leads to a decrease in both serum parathyroid hormone and serum C-..
  31. ncbi Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis
    Pauline M Camacho
    Division of Endocrinology and Metabolism, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA
    Clin Chem Lab Med 46:1345-57. 2008
    ..The aim of this review is to present data which helps elucidate the current role and limitation of BTMs in the management of osteoporosis...
  32. ncbi The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration
    Veerendra Munugalavadla
    Department of Pediatrics, Herman B Wells Center for Pediatric Research, 2 Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Mol Cell Biol 28:7182-98. 2008
    ..to adhere to as well as to migrate via integrin alphavbeta3 was observed, which was associated with reduced bone resorption. Microarray as well as quantitative real-time PCR analysis of p85alpha(-/-) osteoclasts revealed a ..
  33. ncbi Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio
    Riku Kiviranta
    Department of Medical Biochemistry and Molecular Biology, University of Turku, Kiinamyllynkatu 10, FIN 20520 Turku, Finland
    Bone 36:159-72. 2005
    Previous reports indicate that mice deficient for cathepsin K (Ctsk), a key protease in osteoclastic bone resorption, develop osteopetrosis due to their inability to properly degrade organic bone matrix...
  34. ncbi Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption
    Nathan J Pavlos
    Centre for Orthopaedic Research, School of Surgery, University of Western Australia, Perth 6009, Western Australia, Australia
    Mol Cell Biol 31:1551-64. 2011
    ..Finally, targeted disruption of Tctex-1 by RNA interference significantly impairs bone resorption capacity and mislocalizes Rab3D vesicles in osteoclasts, attesting to the notion that components of the Rab3D-..
  35. ncbi Bone turnover markers in the management of postmenopausal osteoporosis
    Jacques P Brown
    Universite Laval, Quebec, QC, Canada
    Clin Biochem 42:929-42. 2009
    ..However, when remodelling becomes accelerated in combination with an imbalance that favours bone resorption over formation, such as during menopause, precipitous losses in bone mass occur...
  36. ncbi Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women
    Matthew T Drake
    Division of Endocrinology and Metabolism, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 95:5063-8. 2010
    It has recently been proposed that the increase in bone resorption after the menopause may not be due principally to estrogen deficiency but rather to the concomitant increase in circulating FSH levels.
  37. ncbi Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency
    B D Gelb
    Department of Human Genetics and Division of Pediatric Cardiology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Science 273:1236-8. 1996
    ..These findings suggest that cathepsin K is a major protease in bone resorption, providing a possible rationale for the treatment of disorders such as osteoporosis and certain forms of ..
  38. ncbi Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption
    Nathan J Pavlos
    Unit of Orthopaedics, School of Surgery and Pathology, University of Western Australia, 2nd Floor M Block, QEII Medical Centre, Nedlands, Perth, Western Australia 6009, Australia
    Mol Cell Biol 25:5253-69. 2005
    ..prenylation-deficient Rab3D has no significant effects, overexpression of GTP-binding-deficient Rab3D impairs bone resorption in vitro...
  39. ncbi Bone formation versus bone resorption in ankylosing spondylitis
    Georg Schett
    Department of Internal Medicine 3, University of Erlangen Nuremberg, Erlangen, Germany
    Adv Exp Med Biol 649:114-21. 2009
    ..AS may thus be considered as a synthesis of inflammatory disease and bone disease...
  40. ncbi Onion and a mixture of vegetables, salads, and herbs affect bone resorption in the rat by a mechanism independent of their base excess
    Roman C Muhlbauer
    Department Clinical Research, University of Bern, Switzerland
    J Bone Miner Res 17:1230-6. 2002
    ..We showed previously that in the rat the consumption of several vegetables, salads, and herbs inhibits bone resorption and that onion increases bone mass...
  41. ncbi Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis
    Andrea Dovio
    Medicina Interna I, Dipartimento di Scienze Cliniche e Biologiche, University of Turin, 10043 Orbassano, Italy
    J Clin Endocrinol Metab 89:4923-8. 2004
    ..regimens cause an immediate and persistent decrease in bone formation and a rapid and transient increase of bone resorption. Our data also support the concept that discontinuation of such regimens is followed by a high bone turnover ..
  42. ncbi The cell biology of osteoclast function
    H K Vaananen
    Skeletal Research Program, Department of Anatomy, Institute of Biomedicine, University of Turku, Finland
    J Cell Sci 113:377-81. 2000
    Osteoclasts are multinucleated cells responsible for bone resorption. They have developed an efficient machinery for dissolving crystalline hydroxyapatite and degrading organic bone matrix rich in collagen fibers...
  43. ncbi Intake of fruit and vegetables: implications for bone health
    Susan A New
    Centre for Nutrition and Food Safety, School of Biomedical and Molecular Sciences, University of Surrey, Guildford GU2 7XH, Surrey, UK
    Proc Nutr Soc 62:889-99. 2003
    ....
  44. ncbi Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice
    P Saftig
    Zentrum Biochemie und Molekulare Zellbiologie, Abteilung Biochemie II, Universitat Gottingen, Gosslerstrasse 12 d, 37073 Gottingen, Germany
    Proc Natl Acad Sci U S A 95:13453-8. 1998
    ..With a view to delineating the role of cathepsin K in bone resorption, we generated mice with a targeted disruption of this proteinase...
  45. ncbi The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation
    N M Peet
    Department of Biology, University of York, U K
    FASEB J 13:2179-85. 1999
    ..Peet, N. M., Grabowski, P. S., Laketic-Ljubojevic, I., Skerry, T. M. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.
  46. ncbi RANK-L and RANK: T cells, bone loss, and mammalian evolution
    Lars E Theill
    Inflammation Drug Discovery Research, One Amgen Center Drive, Thousand Oaks, California 91320-1789, USA
    Annu Rev Immunol 20:795-823. 2002
    ..Modulation of these systems provides us with a unique opportunity to design novel therapeutics to inhibit bone loss in arthritis, periodontal disease, and osteoporosis...
  47. ncbi Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption
    H Zhao
    Department of Anatomy, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, FIN 20520 Turku, Finland
    J Biol Chem 276:39295-302. 2001
    ..These impairments caused a significant inhibition of bone resorption in vitro...
  48. ncbi Meta-analysis of the quantity of calcium excretion associated with the net acid excretion of the modern diet under the acid-ash diet hypothesis
    Tanis R Fenton
    Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
    Am J Clin Nutr 88:1159-66. 2008
    ..A systematic approach has not been used to summarize the findings of the numerous studies about the hypothesis...
  49. ncbi TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
    B S Kwon
    Department of Microbiology and Immunology, and Walther Oncology Center, Indiana University School of Medicine and the Walther Cancer Institute, Indianapolis 46202 5120, USA
    FASEB J 12:845-54. 1998
    ..Anti-TR1 monoclonal antibody promoted the formation of osteoclasts in mouse marrow culture assays. These results indicate that TR1 has broad biological activities in fibroblast growth and in osteoclast differentiation and its functions...
  50. ncbi SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27
    Ping Zhou
    Department of Pathology, Washington University School of Medicine, St Louis, MO 63110, USA
    J Immunol 177:8777-84. 2006
    ..The SHIP1/Akt pathway therefore suppresses bone loss in pathological states associated with an excess of the cytokine...
  51. ncbi Severely suppressed bone turnover: a potential complication of alendronate therapy
    Clarita V Odvina
    Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8885, USA
    J Clin Endocrinol Metab 90:1294-301. 2005
    Alendronate, an inhibitor of bone resorption, is widely used in osteoporosis treatment. However, concerns have been raised about potential oversuppression of bone turnover during long-term use...
  52. ncbi Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1
    Jincheng Yan
    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Hum Mol Genet 17:936-48. 2008
    ..lineage-derived cells that resorb bone and NF1 haploinsufficient osteoclasts have abnormal Ras-dependent bone resorption. Ras-regulated functions are in part mediated via the activation of small Rho family of GTPases including the ..
  53. ncbi Dickkopf-1 is a master regulator of joint remodeling
    Danielle Diarra
    Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen Nurnberg, Krankenhausstrasse 12, D 91054 Erlangen, Germany
    Nat Med 13:156-63. 2007
    ..Whereas degenerative osteoarthritis results in the formation of new bone, rheumatoid arthritis leads to bone resorption. The molecular basis of these different patterns of joint disease is unknown...
  54. ncbi The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell
    Zvi Bar-Shavit
    The Hubert H Humphrey Center for Experimental Medicine and Cancer Research, Hebrew University Faculty of Medicine, Jerusalem 91120, Israel
    J Cell Biochem 102:1130-9. 2007
    ..Osteoclasts are formed by the fusion of precursor cells. They function in bone resorption and are therefore critical for normal skeletal development (growth and modeling), for the maintenance of its ..
  55. ncbi Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women
    Bess Dawson-Hughes
    Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111, USA
    J Clin Endocrinol Metab 94:96-102. 2009
    ..Bicarbonate has been implicated in bone health in older subjects on acid-producing diets in short-term studies...
  56. ncbi Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model
    Jukka P Rissanen
    Pharmatest Services Ltd, Itäinen Pitkäkatu 4 C, Turku 20520, Finland
    Calcif Tissue Int 82:108-15. 2008
    ..To study the effects of estrogen withdrawal on osteoclast number and osteoclast activity in the rat ovariectomy (OVX) model...
  57. ncbi Metastasis and bone loss: advancing treatment and prevention
    Robert E Coleman
    Yorkshire Cancer Research Professor of Medical Oncology, Academic Unit of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S102SJ, UK
    Cancer Treat Rev 36:615-20. 2010
    ....
  58. ncbi The collagenolytic activity of cathepsin K is unique among mammalian proteinases
    P Garnero
    INSERM Unit 403, Hopital E Herriot, Pav F, 69437 Lyon Cedex 03, France
    J Biol Chem 273:32347-52. 1998
    ..The degradation of this collagen is a major event during bone resorption, but its mechanism is unknown...
  59. ncbi Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain
    Nicholas Polakowski
    East Carolina University, Department of Microbiology and Immunology, Brody School of Medicine, Greenville, NC 27834, USA
    Retrovirology 7:61. 2010
    ..Hypercalcemia and bone lesions due to osteoclast-mediated bone resorption are frequently associated with more aggressive forms of the disease...
  60. ncbi Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development
    Yingben Xue
    Calcium Research Laboratory, McGill University Health Centre and Department of Medicine, McGill University, Montreal, Quebec H3A 1A1, Canada
    Hum Mol Genet 14:1515-28. 2005
    ..Although PTH and 1,25(OH)2D3 independently, but not additively, regulate osteoclastic bone resorption, they do affect the renal calcium transport pathway cooperatively...
  61. ncbi Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis
    Mariola Kurowska-Stolarska
    University Hospital Zurich, University of Zurich, Zurich, Switzerland
    Arthritis Rheum 60:3663-75. 2009
    ..To map hypoxic areas in arthritic synovium and to establish the relevance of low oxygen levels to the phenotype of synovial fibroblasts, with special focus on bone degradation...
  62. ncbi Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro
    M T K Mulari
    Department of Anatomy and Medicity Research Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland
    Calcif Tissue Int 75:253-61. 2004
    Bone remodeling involves old bone resorption by osteoclasts and new bone formation by osteoblasts. However, the precise cellular mechanisms underlying these consecutive events remain obscure...
  63. ncbi Severe iron deficiency decreases both bone formation and bone resorption in rats
    Shin Ichi Katsumata
    Department of Nutritional Science, Faculty of Applied Bioscience, Tokyo University of Agriculture, Tokyo, Japan
    J Nutr 139:238-43. 2009
    ..These results suggest that severe iron deficiency decreases not only bone formation but also bone resorption.
  64. ncbi A murine model of cholesteatoma-induced bone resorption using autologous dermal implantation
    Holger Sudhoff
    Department of Otorhinolaryngology Head and Neck Surgery, University of Bochum, Germany
    Laryngoscope 113:1022-6. 2003
    To investigate a novel murine model for dermal implant-induced osteolysis analogous to bone resorption observed in middle ear cholesteatoma.
  65. ncbi Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption
    Arpita Chakravarti
    Centre de Recherche en Rhumatologie et Immunologie CRRI, CRCHUL and Department of Medicine, Faculty of Medicine, Universite Laval, Quebec, QC, Canada
    Blood 114:1633-44. 2009
    ..7 cells, respectively, stimulated bone resorption. Transfection of PLB-985 neutrophil-like cells with RANKL antisense RNA reduced osteoclastogenesis...
  66. ncbi Osteoblast function in myeloma
    G David Roodman
    Veterans Affairs Pittsburgh Healthcare System, Research and Development, Pittsburgh, Pennsylvania, USA
    Bone 48:135-40. 2011
    ..levels of bone formation markers, such as alkaline phosphatase and osteocalcin in the setting of increased bone resorption. In contrast, MM patients without bone lesions display balanced bone remodeling with increased ..
  67. ncbi Dietary patterns, bone resorption and bone mineral density in early post-menopausal Scottish women
    A C Hardcastle
    Bone and Musculoskeletal Research Programme, Division of Applied Medicine, University of Aberdeen, Aberdeen, UK
    Eur J Clin Nutr 65:378-85. 2011
    ..Dietary patterns may provide insights into which foods are important and how nutrition affects bone health. The aim of this study was to investigate the associations between dietary patterns, bone turnover and bone mineral density (BMD)...
  68. ncbi Diet-induced acidosis: is it real and clinically relevant?
    Joseph Pizzorno
    Bastyr University, Seattle, WA 98165, USA
    Br J Nutr 103:1185-94. 2010
    ....
  69. ncbi Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease
    Pal Miheller
    Semmelweis University, Second Department of Internal Medicine, Budapest, Hungary
    Dig Dis 24:201-6. 2006
    ..necrosis factor-alpha (TNF-alpha) plays a pivotal role in the pathogenesis of inflammatory bowel diseases and bone resorption as well...
  70. ncbi The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial
    Anders Bonde Jensen
    Aarhus University Hospital, Noerrebrogade 44, Aarhus C, Denmark
    Clin Breast Cancer 10:452-8. 2010
    ..This study assessed the pharmacokinetics, efficacy, and safety of odanacatib, a selective Cat K inhibitor, in reducing markers of bone resorption in women with breast cancer and MBD.
  71. ncbi Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption
    Fumitaka Mizoguchi
    Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 3 10 Kanda Surugadai 2 Chome, Chiyoda ku, Tokyo 101 0062, Japan
    J Cell Biochem 109:866-75. 2010
    ..On the other hand, conditional Dicer deletion in osteoblasts by using 2.3 kb type I collagen-Cre did not affect bone mass. These results indicate that Dicer in osteoclasts controls activity of bone resorption in vivo.
  72. ncbi Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption
    Masakazu Kogawa
    Bone Cell Biology Group, Discipline of Orthopaedics and Trauma, University of Adelaide, North Terrace, Adelaide, South Australia, Australia 5000
    Endocrinology 151:4613-25. 2010
    ..We conclude that 25D metabolism is an important intrinsic mechanism for optimizing osteoclast differentiation, ameliorating osteoclast activity, and potentially promoting the coupling of bone resorption to formation.
  73. ncbi [Expression of osteoclast stimulating and differentiating factors in a murine model of localized inflammatory bone resorption]
    H Sudhoff
    Hals Nasen Ohrenklinik der Ruhr Universität Bochum, St Elisabeth Hospital, Bochum, Germany
    Laryngorhinootologie 83:14-9. 2004
    The pathology associated to cholesteatoma is predominantly a consequence of osteoclast-mediated bone resorption within the middle ear...
  74. ncbi An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis
    P Garnero
    INSERM Research Unit 403, Hôpital E Herriot Pavillon F, 69437 Lyon Cedex 03, France
    Bone 32:20-6. 2003
    Type I collagen fragments are the most sensitive markers of bone resorption in osteoporosis...
  75. ncbi A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment
    Yuko Hiruma
    Department of Medicine Hematology Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA 15240, USA
    Hum Mol Genet 17:3708-19. 2008
    ..These results indicate that this PDB-associated p62 mutation is not sufficient to induce PDB and suggest that additional factors acting together with p62 mutation are necessary for the development of PDB in vivo...
  76. ncbi Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts
    B S Moonga
    The Mount Sinai Bone Program and the Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Endocrinol 173:395-405. 2002
    ..The effects of the related cytokines interleukin-6 (IL-6), leukemia inhibitory factor (LIF) and oncostatin-M on bone resorption and cytosolic Ca(2+) signaling were compared in isolated rat osteoclasts...
  77. ncbi Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism
    Zhenqiang Yao
    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Biol Chem 283:9917-24. 2008
    Interleukin-1 (IL-1) and tumor necrosis factor (TNF) mediate bone resorption in a variety of diseases affecting bone...
  78. ncbi Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy
    Pal Miheller
    2nd Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary
    Inflamm Bowel Dis 13:1379-84. 2007
    ..Long-term infliximab (IFX) maintenance therapy improves the patients' bone mineral density. The effect of IFX on bone metabolism has not yet been clarified. Our aim was to evaluate IFX effects on bone pathology in CD patients...
  79. ncbi Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection
    Robert E Miller
    Department of Cancer Biology, Amgen Washington, 1201 Amgen Court West, Seattle, WA 98119, USA
    J Immunol 179:266-74. 2007
    ..RANK-Fc inhibition of RANKL has antiosteoclast activity at doses that have no detectable immunoregulatory activity, suggesting that RANKL inhibitors be further studied for their potential to treat excess bone loss...
  80. ncbi Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro
    Nancy S Krieger
    Department of Medicine, Division of Nephrology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Bone Miner Res 22:907-17. 2007
    Chronic metabolic acidosis induces net Ca efflux from bone; this osteoclastic bone resorption is mediated by increased osteoblastic prostaglandin synthesis...
  81. ncbi A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats
    Reina Armamento-Villareal
    Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA
    J Bone Miner Res 20:2178-88. 2005
    ..01. This effect was associated with strong inhibition of bone resorption both histologically and biochemically. Furthermore, CHF 4227...
  82. ncbi [Experience of vitamin K2 in Thailand]
    Narong Bunyaratavej
    Engineering and Tissue Growth Laboratory CETGL Mahidol University, Thailand
    Clin Calcium 17:1752-60. 2007
    ..The efficacy of vitamin K(2) will be fulfill benefit after 6 months of administration, prolong use will enhance of bone quality that prevent fracture...
  83. ncbi A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study
    Ashraf F I Nabhan
    Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
    Hum Reprod 21:1320-4. 2006
    Nitric oxide (NO) stimulates bone formation and inhibits bone resorption in vitro. NO donors (nitrates) are inexpensive and widely available, but their value for post-menopausal osteoporosis has never been evaluated in a randomized trial...
  84. ncbi A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application
    Kazuaki Niikura
    Pharmacology Research Laboratories, Astellas Pharma Inc, Ibaraki, Japan
    J Bone Miner Res 20:1579-88. 2005
    ..FR167356 is the first compound of this nature to be tested. It has the potential to be useful for clinical application...
  85. ncbi [Development, physiology, and cell activity of bone]
    P de Baat
    Uit de afdeling Orthopedie Erasmus Medisch Centrum in Rotterdam
    Ned Tijdschr Tandheelkd 112:258-63. 2005
    ..Following this, osteoclasts undergo specific morphological changes. The process of bone destruction starts by acid dissolution of hydroxyapatite. After that osteoclasts start to destruct the organic matrix...
  86. ncbi Energy regulation by the skeleton
    George Wolf
    Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, USA
    Nutr Rev 66:229-33. 2008
    Bones of the skeleton are constantly remodeled through bone resorption by cells called osteoclasts and bone formation by cells called osteoblasts. Both cell types are under multi-hormone control...
  87. ncbi Synthesis and biological evaluation of novel bisphosphonates with dual activities on bone in vitro
    Yuli Xie
    Department of Medicine, Columbia University, NY 10032, USA
    Bioorg Med Chem Lett 15:3267-70. 2005
    ..with various benzoyl groups on side chains have been synthesized and evaluated for activities on both bone resorption and bone formation in vitro...
  88. ncbi [Bone remodeling]
    Ulf H Lerner
    , Medicinska fakulteten,
    Lakartidningen 103:2972-5. 2006
  89. ncbi [Assessment of bone quality. Bone quality of steroid-induced osteoporosis]
    Minqi Li
    Niigata University, Center for Transdisciplinary Research
    Clin Calcium 18:328-35. 2008
    ..osteoporosis has been reported to show reduced osteoblastic bone formation and accelerated osteoclastic bone resorption. However, a fracture risk of patients with steroid-induced osteoporosis is higher than an assumed risk merely ..
  90. ncbi [Long-term bisphosphonate administration and its effect on bone metabolism]
    Hiroshi Hagino
    Rehabilitation Division, Tottori University Hospital Faculty of Medicine, Tottori University, Japan
    Clin Calcium 15:643-7. 2005
    ..There was no adverse effect on bone metabolism with long term BP treatment, and increase in bone mineral density and reduction in fracture risk were retained...
  91. ncbi Identifying genes that regulate bone remodeling as potential therapeutic targets
    Stephen M Krane
    Harvard Medical School and Massachusetts General Hospital, Boston, MA 02129, USA
    J Exp Med 201:841-3. 2005
    Bone remodeling, a coupled process involving bone resorption and formation, is initiated by mechanical signals and is controlled by local and systemic factors that regulate osteoblast and osteoclast differentiation and function...
  92. ncbi [New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody]
    Seiki Wada
    Department of Clinical Science, Faculty of Pharmaceutical Sciences, Josai International University
    Nippon Rinsho 65:459-62. 2007
  93. ncbi Perforation of cancellous bone trabeculae by damage-stimulated remodelling at resorption pits: a computational analysis
    Laoise M McNamara
    Center for Bioengineeing, Deparment of Mechanical Engineering, Trinity College, Dublin, Ireland
    Eur J Morphol 42:99-109. 2005
    ..Therefore we suggest that an increase in resorption depth relative to the thickness of trabeculae may be responsible for trabecular perforation during osteoporosis, rather than simply trabecular fracture due to insufficient strength...
  94. ncbi Markers of bone turnover: biochemical and clinical perspectives
    F Pagani
    Laboratory of Clinical Chemistry, Azienda Ospedaliera Spedali Civili, Brescia, Italy
    J Endocrinol Invest 28:8-13. 2005
    ..osteoblast activity [bone ALP, osteocalcin (OC), procollagene I C- and N-terminal propeptides] and markers of bone resorption, products of the osteocalst activity [pyridinuim crosslinks, collagen I C- and N-terminal telopeptides (CTX-I ..
  95. ncbi Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone
    Oxana P Lazarenko
    Department of Geriatrics, Reynolds Institute on Aging, 629 Jack Stephens Drive, Little Rock, AR 72205, USA
    Endocrinology 148:2669-80. 2007
    ..In conclusion, rosiglitazone induces changes in bone reminiscent of aged bone and appears to induce bone loss by altering the phenotype of marrow mesenchymal stem cells...
  96. ncbi The growing skeleton is a busy place--can biochemical bone markers keep track of the action?
    Frank Rauch
    J Pediatr 153:454-5. 2008
  97. ncbi [Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate]
    Takashi Miki
    Ono Pharmaceutical Co, Ltd, Clinical Planning III Development Planning
    Clin Calcium 17:18-22. 2007
    ..This drug has an inhibitory effect on bone resorption by suppressing the osteoclastic function, and it is being developed as a therapeutic drug of osteoporosis...
  98. ncbi [Melatonin and bone status]
    Zofia Ostrowska
    Slaska Akademia Medyczna w Katowicach, Zakfad Biochemii Klinicznej
    Pol Merkur Lekarski 21:389-93. 2006
    ..Induced by MEL, changes in the level of factors which play a role in the regulation of bone remodelling, may secondarily (directly and/or indirectly through RANKURANK/OPG system) influence on bone status...
  99. ncbi B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo
    Yan Li
    Division of Endocrinology and Metabolism and Lipids, Emory University School of Medicine, 101 Woodruff Circle, Atlanta, GA 30322, USA
    Blood 109:3839-48. 2007
    Bone homeostasis is regulated by a delicate balance between osteoblastic bone formation and osteoclastic bone resorption. Osteoclastogenesis is controlled by the ratio of receptor activator of NF-kappaB ligand (RANKL) relative to its ..
  100. ncbi [Rheumatoid arthritis and osteoporosis: trends in their treatments]
    Yoshiya Tanaka
    First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
    Nippon Rinsho 64:2359-66. 2006
    ..in which GC decreases number of osteoblasts, reduces synthesis of bone matrix proteins from them and enhances bone resorption, resulting in impairment of bone remodeling...
  101. ncbi [Graves' disease and bone metabolism]
    Kanji Sato
    Institute of Clinical Endocrinology, Tokyo Women's Medical University
    Nippon Rinsho 64:2317-22. 2006
    Thyroid hormone stimulates osteoclastic bone resorption, through increased expression of receptor activator of nuclear factor kappa B ligand (RANKL) in osteoblasts as well as via non-RANKL-mediated pathway...

Research Grants81

  1. Biomaterials (Mf/Zn/F-BCPs) for osteoporosis therapy
    Racquel LeGeros; Fiscal Year: 2009
    Osteoporosis, a silent debilitating bone disease, results when the rate of bone resorption (by osteoclasts) is much greater than the rate of bone formation (by osteoblasts) causing bone loss, deterioration of bone quality, leading to ..
  2. Biomaterials (Mf/Zn/F-BCPs) for osteoporosis therapy
    RACQUEL ZAPANTA LEGEROS; Fiscal Year: 2010
    Osteoporosis, a silent debilitating bone disease, results when the rate of bone resorption (by osteoclasts) is much greater than the rate of bone formation (by osteoblasts) causing bone loss, deterioration of bone quality, leading to ..
  3. DEGRADABLE HYDROGELS FOR ORAL DELIVERY OF CALCITONIN
    Jindrich Kopecek; Fiscal Year: 2003
    ..The rationales for hCT use in osteoporosis therapy are the stimulation of osteoblasts, specific inhibition of bone resorption by osteoclasts, and prevention of fusion of osteoclast precursors...
  4. BONE MATRIX AND BONE RESORPTION
    Paul R Odgren; Fiscal Year: 2010
    ..translocate OC secretory vesicles to the RB and secrete their contents into the resorption lacuna to effect bone resorption. Under SA1...
  5. PDGF D AND PROSTATE CANCER BONE METASTASIS
    Hyeong Reh Choi Kim; Fiscal Year: 2010
    ..mechanisms by which prostate carcinoma-produced platelet-derived growth factor (PDGF) regulates osteoclastic bone resorption and new bone growth, creating a favorable microenvironment for metastatic deposit...
  6. Molecular Mechanisms in Bone Resorption
    Steven A Lietman; Fiscal Year: 2010
    ..of the etiology, osteoporosis is characterized by an imbalance in bone remodeling, such that osteoclastic bone resorption exceeds osteoblastic bone formation, which leads to low bone mass or osteopenia...
  7. Molecular Mechanisms in Bone Resorption
    STEVEN LIETMAN; Fiscal Year: 2009
    ..of the etiology, osteoporosis is characterized by an imbalance in bone remodeling, such that osteoclastic bone resorption exceeds osteoblastic bone formation, which leads to low bone mass or osteopenia...
  8. Immune Cytokines Promote Oral Bone Loss Through IKK
    Cun Yu Wang; Fiscal Year: 2010
    ..Under physiological condition, bone resorption is delicately balanced and coupled with bone extracellular matrix deposition or bone formation, ensuring that ..
  9. Innate Immune Bacterial Recognition and Osteoclastogenesis
    Caroline A Genco; Fiscal Year: 2010
    ..In other inflammatory bone diseases these cells have been reported to contribute to the acceleration of bone resorption by the production of proinflammatory cytokines including tumor necrosis factor (TNF)-, interleukin (IL)-1, IL-..
  10. The Effect of PTHrP During Lactation
    John J Wysolmerski; Fiscal Year: 2010
    ..The resulting low estrogen levels, in turn, accelerate bone resorption and cause bone loss. In addition, the lactating breast secretes PTHrP into the systemic circulation and milk...
  11. The Effect of PTHrP During Lactation
    John Wysolmerski; Fiscal Year: 2007
    ..The resulting low estrogen levels, in turn, accelerate bone resorption and cause bone loss. In addition, the lactating breast secretes PTHrP into the systemic circulation and milk...
  12. CELLULAR BASIS OF CRANIOFACIAL BONE DISORDERS
    Philip Osdoby; Fiscal Year: 2002
    ..and activity and therefore influence normal and pathological osteoclastogenesis and osteoclast-mediated bone resorption. We have shown that osteoclasts produce small proinflammatory molecules known as chemokines, such as IL-8 and ..
  13. MVNP, p62P392L and IL-6 in the Pathogenesis of PD
    G Roodman; Fiscal Year: 2009
    ..both the p38 MAPK and PLC32/CREB pathways to increase IL-6 production, OCL numbers, nuclei per OCL and OCL bone resorption capacity...
  14. BONE TARGETED DELIVERY OF ANABOLIC AGENTS
    Jindrich Kopecek; Fiscal Year: 2009
    ..Previous experiments have demonstrated that D-Asp8-targeted conjugates are preferentially incorporated onto bone resorption surfaces. This offers a unique opportunity to target drugs to sites of active bone resorption...
  15. BONE TARGETED DELIVERY OF ANABOLIC AGENTS
    JINDRICH H KOPECEK; Fiscal Year: 2010
    ..Previous experiments have demonstrated that D-Asp8-targeted conjugates are preferentially incorporated onto bone resorption surfaces. This offers a unique opportunity to target drugs to sites of active bone resorption...
  16. MATRIX PROTEIN/INTEGRIN MEDIATED OSTEOCLAST REGULATION
    Keith Hruska; Fiscal Year: 1999
    ..progress has been made in the understanding of bone remodeling, especially related to the cell biology of bone resorption, in recent years...
  17. BONE MATRIX AND BONE RESORPTION
    PAUL ODGREN; Fiscal Year: 2006
    These studies, all derived from our previous work exploring the interactions of bone matrix and bone resorption, focus on genes and other factors impacting skeletal development and resorption...
  18. ROLE FOR IL6 IN PTH INDUCED BONE RESORPTION
    Karl Insogna; Fiscal Year: 2001
    ..Of the various subtypes of this disease, postmenopausal osteoporosis is by far the most common. Increased bone resorption is the principal mechanism for bone loss in postmenopausal osteoporosis, and recent evidence indicates that ..
  19. BONE MATRIX AND BONE RESORPTION
    PAUL ODGREN; Fiscal Year: 2009
    ..It is a competitive revision request for grant RO1 DE 007444, "Bone matrix and bone resorption," under which we are investigating the osteoclast cell biology of a protein we discovered called plekhm1...
  20. ENDOSTEAL BONE VOLUME REGULATION AND OSTEOPOROSIS
    Subburaman Mohan; Fiscal Year: 2010
    ..Instead, this reduction in trabecular bone volume in Cldn-18 knockout mice is caused by increased bone resorption as reflected by increased osteoclast (OC) number that is not compensated by a corresponding increase in ..
  21. The Mechanism of Coupling Bone Resorption and Formation
    Xu Cao; Fiscal Year: 2007
    ..The sequence is always the same - activation of osteoclast precursors and osteoclastic bone resorption, followed by osteoblastic bone formation to repair the defects...
  22. Effect of HIV Infection and HAART on Bone Homeostasis
    MERVYN NEALE contact WEITZMANN; Fiscal Year: 2010
    ..Osteoclasts the cells responsible for bone resorption form under the influence of the key osteoclastogenic cytokine Receptor- Activator of NF-:B (RANKL)...
  23. The Role Of Osteoclast PODXL, A Mediator Of Cell Adhesion, In Bone Metabolism
    Merry Jo Oursler; Fiscal Year: 2010
    ..Thus, loss of PODXL in early osteoclast lineage cells reduces bone resorption while preserving osteoblast recruitment and bone formation...
  24. COLONY STIMULATING FACTOR 1 REGULATION AND ROLE IN BONE
    Karl Insogna; Fiscal Year: 2002
    The precise mechanism whereby osteoblasts mediate osteoclastic bone resorption is unclear. One widely-held hypothesis is that activated osteoblasts secrete cytokines that directly or indirectly influence osteoclast formation or function...
  25. Breast Cancer Osteolysis--Regulation of PTHrP by TGFBeta
    Theresa Guise; Fiscal Year: 2005
    ..protein (PTHrP), originally identified as a hypercalcemic factor and a known stimulator of osteoclastic bone resorption, is a major mediator of the osteolytic process...
  26. CYTOKINE REGULATION OF RA SYNOVIOCYTE PHENOTYPE
    Lionel B Ivashkiv; Fiscal Year: 2010
    ..in RA pathogenesis by production of cytokines that drive inflammation, and osteoclasts mediate pathologic bone resorption. Osteoclast differentiation is dependent on the TNF family member RANKL...
  27. Amelioration of Immune Cell-Mediated Periodontal Disease
    Martin A Taubman; Fiscal Year: 2010
    ..demonstrated unequivocally that host immune responses play a key role in activating osteoclasts and promoting bone resorption in periodontal disease...
  28. Amelioration of Immune Cell-Mediated Periodontal Disease
    Martin Taubman; Fiscal Year: 2009
    ..demonstrated unequivocally that host immune responses play a key role in activating osteoclasts and promoting bone resorption in periodontal disease...